These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 7595698)

  • 61. Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial.
    Mahoney DH; Shuster J; Nitschke R; Lauer SJ; Winick N; Steuber CP; Camitta B
    J Clin Oncol; 1998 Jan; 16(1):246-54. PubMed ID: 9440749
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of maintenance treatment regimens for first central nervous system relapse in children with acute lymphocytic leukemia. A Pediatric Oncology Group study.
    Land VJ; Thomas PR; Boyett JM; Glicksman AS; Culbert S; Castleberry RP; Berry DH; Vats T; Humphrey GB
    Cancer; 1985 Jul; 56(1):81-7. PubMed ID: 3859359
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
    Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
    Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-leukemic treatment-induced neurotoxicity in long-term survivors of childhood acute lymphoblastic leukemia: impact of reduced central nervous system radiotherapy and intermediate- to high-dose methotrexate.
    Zając-Spychała O; Pawlak M; Karmelita-Katulska K; Pilarczyk J; Jończyk-Potoczna K; Przepióra A; Derwich K; Wachowiak J
    Leuk Lymphoma; 2018 Oct; 59(10):2342-2351. PubMed ID: 29424258
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cranial computed tomography in children with acute lymphoblastic leukemia after prophylactic treatment with cranial radiation therapy and intrathecal methotrexate.
    Liang DC; Lin JC; Shih SL; Huang JK; Wong LY; Shu SG; Hsieh YL; Yang CP; Tsai YM; Lin ST
    Cancer; 1993 Mar; 71(6):2105-8. PubMed ID: 8443759
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia.
    Wolfrom C; Hartmann R; Fengler R; Brühmüller S; Ingwersen A; Henze G
    J Clin Oncol; 1993 May; 11(5):827-33. PubMed ID: 8487046
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long-term psychological effects of childhood leukemia and its treatment.
    Jannoun L; Chessells JM
    Pediatr Hematol Oncol; 1987; 4(4):293-308. PubMed ID: 2484651
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy.
    Zając-Spychała O; Pawlak MA; Karmelita-Katulska K; Pilarczyk J; Derwich K; Wachowiak J
    Neuroradiology; 2017 Feb; 59(2):147-156. PubMed ID: 28074235
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy of intrathecal methotrexate with and without cranial radiotherapy in preventing central nervous system relapses in acute lymphocytic leukemia.
    Choudhry VP; Krishnamurthy L; Rath GK; Arya LS; Pati H; Saraya AK
    Indian Pediatr; 1992 Jul; 29(7):843-9. PubMed ID: 1428132
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Analysis of growth failure in children treated for acute lymphoblastic leukemia.
    Sato J; Ninomiya T; Tsuda Y; Komazawa M; Nagata K; Iwai A; Nishikawa K; Maeda H; Ohmiya A; Ohta M
    Int J Hematol; 1992 Dec; 56(3):205-12. PubMed ID: 1477332
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma.
    Razzouk BI; Rose SR; Hongeng S; Wallace D; Smeltzer MP; Zacher M; Pui CH; Hudson MM
    J Clin Oncol; 2007 Apr; 25(10):1183-9. PubMed ID: 17401007
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of the late effects of CNS prophylactic treatment in childhood acute lymphoblastic leukemia (ALL) using magnetic resonance spectroscopy.
    Ficek K; Blamek S; Syguła D; Miszczyk L; Sońta-Jakimczyk D; Tarnawski R
    Acta Neurochir Suppl; 2010; 106():195-7. PubMed ID: 19812948
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cognitive functioning in long-term survivors of childhood leukemia: a prospective analysis.
    Rubenstein CL; Varni JW; Katz ER
    J Dev Behav Pediatr; 1990 Dec; 11(6):301-5. PubMed ID: 2289962
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Memory and learning sequelae in long-term survivors of acute lymphoblastic leukemia: association with attention deficits.
    Brouwers P; Poplack D
    Am J Pediatr Hematol Oncol; 1990; 12(2):174-81. PubMed ID: 2116096
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score.
    Silber JH; Radcliffe J; Peckham V; Perilongo G; Kishnani P; Fridman M; Goldwein JW; Meadows AT
    J Clin Oncol; 1992 Sep; 10(9):1390-6. PubMed ID: 1517781
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study.
    Camitta B; Mahoney D; Leventhal B; Lauer SJ; Shuster JJ; Adair S; Civin C; Munoz L; Steuber P; Strother D
    J Clin Oncol; 1994 Jul; 12(7):1383-9. PubMed ID: 8021728
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Combination of radio-chemotherapy for curing of childhood hematologic tumors: preventive approaches and problems on CNS involvement].
    Fujimoto T
    Gan No Rinsho; 1988 Oct; 34(13):1903-8. PubMed ID: 3199522
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group.
    Hardy KK; Embry L; Kairalla JA; Helian S; Devidas M; Armstrong D; Hunger S; Carroll WL; Larsen E; Raetz EA; Loh ML; Yang W; Relling MV; Noll RB; Winick N
    J Clin Oncol; 2017 Aug; 35(23):2700-2707. PubMed ID: 28671857
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of meningeal relapse in childhood acute lymphoblastic leukemia: II. A prospective study of intellectual loss specific to CNS relapse and therapy.
    Longeway K; Mulhern R; Crisco J; Kun L; Lauer S; Casper J; Camitta B; Hoffman RG
    Am J Pediatr Hematol Oncol; 1990; 12(1):45-50. PubMed ID: 2309979
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy.
    Vora A; Andreano A; Pui CH; Hunger SP; Schrappe M; Moericke A; Biondi A; Escherich G; Silverman LB; Goulden N; Taskinen M; Pieters R; Horibe K; Devidas M; Locatelli F; Valsecchi MG
    J Clin Oncol; 2016 Mar; 34(9):919-26. PubMed ID: 26755523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.